@article {856,
	title = {Antilymphocyte globulin for treatment of pure red cell aplasia after major ABO incompatible marrow transplant},
	journal = {Bone Marrow Transplant},
	volume = {10},
	year = {1992},
	note = {Labar, B Bogdanic, V Nemet, D Kovacevic-Metelko, J Mrsic, M Pavletic, Z Zupancic-Salek, S Radman, I Aurer, I Case Reports Research Support, Non-U.S. Gov{\textquoteright}t England Bone marrow transplantation Bone Marrow Transplant. 1992 Nov;10(5):471-2.},
	month = {Nov},
	pages = {471 - 2},
	edition = {33909},
	abstract = {A patient developed pure red cell aplasia after ABO incompatible BMT for leukemia. He did not respond to plasma exchange. Antilymphocyte globulin therapy was followed by complete and permanent erythroid recovery with disappearance of recipient-derived isoagglutinins.},
	keywords = {*ABO Blood-Group System, Adult, Antilymphocyte Serum / *therapeutic use, Blood Group Incompatibility / *etiology, Bone Marrow Transplantation / *adverse effects, Humans, Male, Precursor Cell Lymphoblastic Leukemia-Lymphoma / *surgery, Red-Cell Aplasia, Pure / *drug therapy / etiology},
	issn = {0268-3369 (Print) 0268-3369 (Linking)},
	author = {Labar,B. and Bogdanic,V. and Nemet,D. and Kovacevic-Metelko,J. and Mrsic,M. and Pavletic,Z. and Zupancic-Salek,S. and Radman,I. and Aurer,I.}
}
